Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 74

Results For "HR"

6330 News Found

Orange Health records Rs 138 crore revenue at 65% annual growth in FY26
Startup | April 28, 2026

Orange Health records Rs 138 crore revenue at 65% annual growth in FY26

The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities


Aurigene bets big on CRDMO expansion with $100 million outlay
News | April 28, 2026

Aurigene bets big on CRDMO expansion with $100 million outlay

Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities


Ahmedabad hosts national conclave on urban pest and vector control strategies
Policy | April 28, 2026

Ahmedabad hosts national conclave on urban pest and vector control strategies

Experts call for integrated, evidence-based approaches to tackle rising dengue, malaria, and chikungunya burden in Indian cities


AbbVie seeks FDA nod for subcutaneous SKYRIZI induction in Crohn’s disease
Drug Approval | April 28, 2026

AbbVie seeks FDA nod for subcutaneous SKYRIZI induction in Crohn’s disease

The submission is backed by positive results from the Phase 3 AFFIRM study


LVPEI launches Eye and Brain Centre in Hyderabad with support from D. E. Shaw India
Hospitals | April 27, 2026

LVPEI launches Eye and Brain Centre in Hyderabad with support from D. E. Shaw India

The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders


Indian Immunologicals clocks all-time high revenue of Rs 1,586 crore in FY26
Biopharma | April 27, 2026

Indian Immunologicals clocks all-time high revenue of Rs 1,586 crore in FY26

Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%


Prof. Gobardhan Das appointed to NITI Aayog; PM Modi commends his contributions to R&D
People | April 27, 2026

Prof. Gobardhan Das appointed to NITI Aayog; PM Modi commends his contributions to R&D

His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research


Wellness travel is moving closer to home: What’s driving the shift?
Opinion | April 27, 2026

Wellness travel is moving closer to home: What’s driving the shift?

India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle


Sun Pharma to acquire Organon in $11.75 billion all-cash deal
News | April 27, 2026

Sun Pharma to acquire Organon in $11.75 billion all-cash deal

Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally


Nihilent unveils nSEPIA Beta to turn emotional wellness into measurable science
News | April 27, 2026

Nihilent unveils nSEPIA Beta to turn emotional wellness into measurable science

nSEPIA aims to bring structure to an area long dominated by subjectivity